# A Study to Assess Tolerability of the Trivalent Recombinant Vaccine in Individuals Aged 18 and Older Using the Vaccinees Perception of Injection Questionnaire

> **NCT06765187** · — · COMPLETED · sponsor: **Sanofi** · enrollment: 1007 (actual)

## Conditions studied

- Influenza Immunization
- Health Volunteers

## Interventions

- **BIOLOGICAL:** Trivalent Recombinant Influenza Vaccine

## Key facts

- **NCT ID:** NCT06765187
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-18
- **Primary completion:** 2025-12-22
- **Final completion:** 2025-12-22
- **Target enrollment:** 1007 (ACTUAL)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06765187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06765187, "A Study to Assess Tolerability of the Trivalent Recombinant Vaccine in Individuals Aged 18 and Older Using the Vaccinees Perception of Injection Questionnaire". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06765187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*